Could Antinuclear Antibody Positivity Be a Factor Affecting Treatment Response in Immune Thrombocytopenia Patients on Eltrombopag?

Objective: Eltrombopag remains a prominent option in the treatment of steroid-dependent or steroid-refractory immune thrombocytopenia (ITP) patients. Unfortunately, not all patients respond to eltrombopag. Antinuclear antibody (ANA) positivity can be seen at rates of up to 30% in ITP patients. Despi...

Full description

Bibliographic Details

Published in:	Turkish Journal of Hematology
Main Authors:	Mehmet Baysal, Volkan Baş, Elif Ümit, Hakkı Onur Kırkızlar, Ahmet Muzaffer Demir
Format:	Article
Language:	English
Published:	Turkish Society of Hematology 2022-02-01
Subjects:	antinuclear antibodies eltrombopag immune thrombocytopenia
Online Access:	https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tjh&un=TJH-25593